Glycyrrhiza Glabra Pellet
Product Images NDC 0220-2305

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Glycyrrhiza Glabra (NDC 0220-2305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boiron, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Glygla30c

Glygla30c
This is a description of a homeopathic medicine named Glycyrrhiza glabra 30°, manufactured in France by Boirgn'. It is a prescription drug and contains 80 pellets each having 0.443 mg of active ingredient. It is used to relieve symptoms as mentioned on the front panel. Users are warned that if symptoms persist for more than 3 days or worsen, they should seek a doctor's advice. It is also suggested to consult a doctor before consumption if pregnant or breastfeeding. The prescribed dose is to dissolve 5 pellets under the tongue 3 times a day. The drug contains inactive ingredients like lactose and sucrose. There are instructions provided on how to dispense the pellets. The mentioned text is the complete drug fact on this medicine.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.